News Releases

Leading New Gene-based Therapies


Enochian Biosciences Announces Three Scientific Presentations on Potential HIV and HBV Cures

May 13, 2020


Enochian Biosciences Announces Scientific Presentations at the American Society of Cell and Gene Therapy (ASCGT) Annual Meeting

April 9, 2020


Enochian Biosciences Announces FDA INTERACT Meeting for a Potential Cure for HIV

February 24, 2020


Enochian Biosciences Acquires an Exclusive License for a Novel Hepatitis B Virus Potential Treatment or Cure

February 3, 2020


Enochian Biosciences, A Company Focused on Gene-Modified Cellular Therapy in Infectious Disease and Cancer, Announces the Appointment of Two Board Members

January 8, 2020


Enochian Biosciences Announces Scientific Presentation of a Novel Approach to Potentially Cure Hepatitis B Virus

December 10, 2019


Enochian Biosciences Expands its Infectious Disease Pipeline by Entering into an Agreement in Principle to Acquire an Exclusive License for a Novel Hepatitis B Virus Treatment

November 25, 2019


Enochian BioSciences Inventor Named to Two Important Scientific Committees

June 3, 2019


Enochian Biosciences Announces Appointment of Dr. Mark Dybul as Executive Vice-Chair

January 7, 2019


Enochian Biosciences Announces Uplisting to NASDAQ Under Symbol “ENOB”

December 5, 2018


Enochian Biosciences Attending 60th ASH on Nov 30-Dec 4 in San Diego, CA

November 27, 2018


Enochian Biosciences to Present at Biotech Showcase 2019

November 23, 2018